首页> 美国卫生研究院文献>Frontiers in Microbiology >Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases
【2h】

Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases

机译:基于益生菌的多种胃肠道疾病的治疗和预防策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Probiotic bacteria offer a number of potential health benefits when administered in sufficient amounts that in part include reducing the number of harmful organisms in the intestine, producing antimicrobial substances and stimulating the body’s immune response. However, precisely elucidating the probiotic effect of a specific bacterium has been challenging due to the complexity of the gut’s microbial ecosystem and a lack of definitive means for its characterization. This review provides an overview of widely used and recently described probiotics, their impact on the human’s gut microflora as a preventative treatment of disease, human/animal models being used to help show efficacy, and discusses the potential use of probiotics in gastrointestinal diseases associated with antibiotic administration.
机译:施用足够量的益生菌可带来许多潜在的健康益处,其中一部分包括减少肠道中有害生物的数量,产生抗微生物物质和刺激人体的免疫反应。然而,由于肠道微生物生态系统的复杂性以及缺乏确定其特征的明确方法,精确阐明特定细菌的益生菌效应一直是一项挑战。这篇综述概述了最近广泛使用的益生菌,它们作为预防疾病对人类肠道菌群的影响,用于帮助显示功效的人/动物模型,并讨论了益生菌在与胃肠道疾病相关的潜在用途抗生素管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号